Skip to main content
Equibles

Parcion Private Wealth LLC

Position in FATE — Fate Therapeutics Inc

CIK 1801263 BELLEVUE, WA
Back to FATE Full portfolio

Position in FATE

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$58,198
+$38,437 QoQ
Shares Held
21,555
+30.9% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#88
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Parcion Private Wealth LLC holds $2,809,080 across 8 Biotechnology names. FATE ranks #8 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 5,633 $638,556
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,022 $637,257
3 EXEL
Exelixis, Inc.
 11,443 $622,613
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 596 $296,051
5 BMRN
Biomarin Pharmaceutical Inc
 4,579 $262,010
6 JAZZ
Jazz Pharmaceuticals plc
 944 $227,475
7 MNKD
Mannkind Corp
 15,709 $66,920
8 FATE
Fate Therapeutics Inc
This page 		21,555 $58,198

All Filings in FATE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $58,198 21,555
2026-03-31 $19,761 16,468
2025-12-31 $13,775 14,057
2025-09-30 $18,230 14,469
2025-06-30 $34,479 30,785
2025-03-31 $24,010 30,393
2024-12-31 $46,200 28,000
2024-09-30 $98,000 28,000
2024-06-30 $91,840 28,000
2024-03-31 $205,520 28,000
2023-12-31 $104,720 28,000
2023-09-30 $59,360 28,000
2023-06-30 $133,280 28,000
2023-03-31 $159,600 28,000
2022-12-31 $282,520 28,000
2022-09-30 $627,480 28,000
2022-06-30 $693,840 28,000
2022-03-31 $1,085,560 28,000
2021-12-31 $1,638,280 28,000
2021-09-30 $1,659,560 28,000
2021-06-30 $2,430,120 28,000
2021-03-31 $2,308,600 28,000
2020-12-31 $2,546,040 28,000
2020-09-30 $1,119,160 28,000
2020-06-30 $960,680 28,000
2020-03-31 $621,880 28,000